Nutrient Sensing Overrides Somatostatin and Growth Hormone-Releasing Hormone to Control Pulsatile Growth Hormone Release

Journal of Neuroendocrinology

Volumn 27, Issue 7, 2015, Pages 577-587

  Steyn, F J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Feedback; Food intake; Glucose; Growth hormone; Neuropeptide Y; Pulsatility

Indexed keywords

GHRELIN; GLUCOSE; GROWTH HORMONE RELEASING FACTOR; NEUROPEPTIDE Y; SOMATOSTATIN; GROWTH HORMONE;

ADENOHYPOPHYSIS; ARTICLE; BRAIN PERICYTE; BRAIN REGION; CALCIUM SIGNALING; CELL INTERACTION; FEEDBACK SYSTEM; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GROWTH HORMONE RELEASE; GROWTH HORMONE SECRETING CELL; HUMAN; HYPOPHYSIS FUNCTION; IN VIVO STUDY; MEDIAN EMINENCE; NONHUMAN; NUTRIENT SENSING; PORTAL VEIN BLOOD; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; SLEEP PATTERN; SLEEP WAKING CYCLE; SOMATOSTATIN RELEASE; TANYCYTE; ANIMAL; FOOD; HYPOPHYSIS; HYPOTHALAMUS; METABOLISM; SECRETION (PROCESS);

ANIMALS; FOOD; GROWTH HORMONE; GROWTH HORMONE-RELEASING HORMONE; HUMANS; HYPOTHALAMUS; NEUROPEPTIDE Y; PITUITARY GLAND; SOMATOSTATIN;

EID: 84932123701     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/jne.12278     Document Type: Article

References (103)

1. Giordano R, Bonelli L, Marinazzo E, Ghigo E, Arvat E. Growth hormone treatment in human ageing: benefits and risks. Hormones 2008; 7: 133-139.
2. Veldhuis JD, Anderson SM, Shah N, Bray M, Vick T, Gentili A, Mulligan T, Johnson ML, Weltman A, Evans WS, Iranmanesh A. Neurophysiological regulation and target-tissue impact of the pulsatile mode of growth hormone secretion in the human. Growth Horm IGF Res 2001; 11 (Suppl A): S25-S37.
3. Holl RW, Hartman ML, Veldhuis JD, Taylor WM, Thorner MO. Thirty-second sampling of plasma growth hormone in man: correlation with sleep stages. J Clin Endocrinol Metab 1991; 72: 854-861.
4. Tolle V, Bassant MH, Zizzari P, Poindessous-Jazat F, Tomasetto C, Epelbaum J, Bluet-Pajot MT. Ultradian rhythmicity of ghrelin secretion in relation with GH, feeding behavior, and sleep-wake patterns in rats. Endocrinology 2002; 143: 1353-1361.
5. Tannenbaum GS, Zhang WH, Lapointe M, Zeitler P, Beaudet A. Growth hormone-releasing hormone neurons in the arcuate nucleus express both Sst1 and Sst2 somatostatin receptor genes. Endocrinology 1998; 139: 1450-1453.
6. Shimon I, Taylor JE, Dong JZ, Bitonte RA, Kim S, Morgan B, Coy DH, Culler MD, Melmed S. Somatostatin receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation. J Clin Invest 1997; 99: 789-798.
7. Isgaard J, Carlsson L, Isaksson OG, Jansson JO. Pulsatile intravenous growth hormone (GH) infusion to hypophysectomized rats increases insulin-like growth factor I messenger ribonucleic acid in skeletal tissues more effectively than continuous GH infusion. Endocrinology 1988; 123: 2605-2610.
8. Cersosimo E, Danou F, Persson M, Miles JM. Effects of pulsatile delivery of basal growth hormone on lipolysis in humans. Am J Physiol 1996; 271: E123-E126.
9. Plotsky PM, Vale W. Patterns of growth hormone-releasing factor and somatostatin secretion into the hypophysial-portal circulation of the rat. Science 1985; 230: 461-463.
10. Frohman LA, Downs TR, Clarke IJ, Thomas GB. Measurement of growth hormone-releasing hormone and somatostatin in hypothalamic-portal plasma of unanesthetized sheep. Spontaneous secretion and response to insulin-induced hypoglycemia. J Clin Invest 1990; 86: 17-24.
11. Thomas GB, Cummins JT, Francis H, Sudbury AW, McCloud PI, Clarke IJ. Effect of restricted feeding on the relationship between hypophysial portal concentrations of growth hormone (GH)-releasing factor and somatostatin, and jugular concentrations of GH in ovariectomized ewes. Endocrinology 1991; 128: 1151-1158.
12. Cataldi M, Magnan E, Guillaume V, Dutour A, Conte-Devolx B, Lombardi G, Oliver C. Relationship between hypophyseal portal GHRH and somatostatin and peripheral GH levels in the conscious sheep. J Endocrinol Invest 1994; 17: 717-722.
13. Mogi K, Yonezawa T, Chen DS, Li JY, Suzuki M, Yamanouchi K, Sawasaki T, Nishihara M. Relationship between growth hormone (GH) pulses in the peripheral circulation and GH-releasing hormone and somatostatin profiles in the cerebrospinal fluid of goats. J Vet Med Sci 2004; 66: 1071-1078.
14. Yonezawa T, Mogi K, Li JY, Sako R, Manabe N, Yamanouchi K, Nishihara M. Negative correlation between neuropeptide Y profile in the cerebrospinal fluid and growth hormone pulses in the peripheral circulation in goats. Neuroendocrinology 2010; 91: 308-317.
15. Giustina A, Veldhuis JD. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev 1998; 19: 717-797.
16. Minami S, Kamegai J, Sugihara H, Suzuki N, Wakabayashi I. Growth hormone inhibits its own secretion by acting on the hypothalamus through its receptors on neuropeptide Y neurons in the arcuate nucleus and somatostatin neurons in the periventricular nucleus. Endocr J 1998; 45(Suppl): S19-S26.
17. Burton KA, Kabigting EB, Steiner RA, Clifton DK. Identification of target cells for growth hormone's action in the arcuate nucleus. Am J Physiol 1995; 269: E716-E722.
18. Steyn FJ, Huang L, Ngo ST, Leong JW, Tan HY, Xie TY, Parlow AF, Veldhuis JD, Waters MJ, Chen C. Development of a method for the determination of pulsatile growth hormone secretion in mice. Endocrinology 2011; 152: 3165-3171.
19. Luque RM, Park S, Kineman RD. Severity of the catabolic condition differentially modulates hypothalamic expression of growth hormone-releasing hormone in the fasted mouse: potential role of neuropeptide Y and corticotropin-releasing hormone. Endocrinology 2007; 148: 300-309.
20. Steyn FJ, Leong JW, Huang L, Tan HY, Xie TY, Nelson C, Waters MJ, Veldhuis JD, Epelbaum J, Chen C. GH does not modulate the early fasting-induced release of free fatty acids in mice. Endocrinology 2012; 153: 273-282.
21. Hanson ES, Dallman MF. Neuropeptide Y (NPY) may integrate responses of hypothalamic feeding systems and the hypothalamo-pituitary-adrenal axis. J Neuroendocrinol 1995; 7: 273-279.
22. Kohno D, Yada T. Arcuate NPY neurons sense and integrate peripheral metabolic signals to control feeding. Neuropeptides 2012; 46: 315-319.
23. Nyberg F. Aging effects on growth hormone receptor binding in the brain. Exp Gerontol 1997; 32: 521-528.
24. Chan YY, Steiner RA, Clifton DK. Regulation of hypothalamic neuropeptide-Y neurons by growth hormone in the rat. Endocrinology 1996; 137: 1319-1325.
25. Tillet Y, Picard S, Bruneau G, Ciofi P, Wankowska M, Wojcik-Gladysz A, Polkowska J. Hypothalamic arcuate neuropeptide Y-neurons decrease periventricular somatostatin-neuronal activity before puberty in the female lamb: morphological arguments. J Chem Neuroanat 2010; 40: 265-271.
26. Hisano S, Tsuruo Y, Kagotani Y, Daikoku S, Chihara K. Immunohistochemical evidence for synaptic connections between neuropeptide Y-containing axons and periventricular somatostatin neurons in the anterior hypothalamus in rats. Brain Res 1990; 520: 170-177.
27. Huang L, Tan HY, Fogarty MJ, Andrews ZB, Veldhuis JD, Herzog H, Steyn FJ, Chen C. Actions of NPY, and its Y1 and Y2 receptors on pulsatile growth hormone secretion during the fed and fasted state. J Neurosci 2014; 34: 16309-16319.
28. Tatemoto K, Carlquist M, Mutt V. Neuropeptide Y - a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 1982; 296: 659-660.
29. Allen YS, Adrian TE, Allen JM, Tatemoto K, Crow TJ, Bloom SR, Polak JM. Neuropeptide Y distribution in the rat brain. Science 1983; 221: 877-879.
30. Morris BJ. Neuronal localisation of neuropeptide Y gene expression in rat brain. J Comp Neurol 1989; 290: 358-368.
31. Haas DA, George SR. Neuropeptide Y-induced effects on hypothalamic corticotropin-releasing factor content and release are dependent on noradrenergic/adrenergic neurotransmission. Brain Res 1989; 498: 333-338.
32. Bennett PA, Thomas GB, Howard AD, Feighner SD, van der Ploeg LH, Smith RG, Robinson IC. Hypothalamic growth hormone secretagogue-receptor (GHS-R) expression is regulated by growth hormone in the rat. Endocrinology 1997; 138: 4552-4557.
33. Chan YY, Clifton DK, Steiner RA. Role of NPY neurones in GH-dependent feedback signalling to the brain. Horm Res 1996; 45(Suppl 1): 12-14.
34. Egecioglu E, Bjursell M, Ljungberg A, Dickson SL, Kopchick JJ, Bergstrom G, Svensson L, Oscarsson J, Tornell J, Bohlooly YM. Growth hormone receptor deficiency results in blunted ghrelin feeding response, obesity, and hypolipidemia in mice. Am J Physiol Endocrinol Metab 2006; 290: E317-E325.
35. Ciofi P, Croix D, Tramu G. Coexistence of hGHRF and NPY immunoreactivities in neurons of the arcuate nucleus of the rat. Neuroendocrinology 1987; 45: 425-428.
36. Ciofi P, Tramu G, Bloch B. Comparative immunohistochemical study of the distribution of neuropeptide Y, growth hormone-releasing factor and the carboxyterminus of precursor protein GHRF in the human hypothalamic infundibular area. Neuroendocrinology 1990; 51: 429-436.
37. Ciofi P, Croix D, Tramu G. Colocalization of GHRF and NPY immunoreactivities in neurons of the infundibular area of the human brain. Neuroendocrinology 1988; 47: 469-472.
38. Harfstrand A, Eneroth P, Agnati L, Fuxe K. Further studies on the effects of central administration of neuropeptide Y on neuroendocrine function in the male rat: relationship to hypothalamic catecholamines. Regul Pept 1987; 17: 167-179.
39. Catzeflis C, Pierroz DD, Rohner-Jeanrenaud F, Rivier JE, Sizonenko PC, Aubert ML. Neuropeptide Y administered chronically into the lateral ventricle profoundly inhibits both the gonadotropic and the somatotropic axis in intact adult female rats. Endocrinology 1993; 132: 224-234.
40. Pierroz DD, Catzeflis C, Aebi AC, Rivier JE, Aubert ML. Chronic administration of neuropeptide Y into the lateral ventricle inhibits both the pituitary-testicular axis and growth hormone and insulin-like growth factor I secretion in intact adult male rats. Endocrinology 1996; 137: 3-12.
41. Raposinho PD, Pierroz DD, Broqua P, White RB, Pedrazzini T, Aubert ML. Chronic administration of neuropeptide Y into the lateral ventricle of C57BL/6J male mice produces an obesity syndrome including hyperphagia, hyperleptinemia, insulin resistance, and hypogonadism. Mol Cell Endocrinol 2001; 185: 195-204.
42. Wagner C, Caplan SR, Tannenbaum GS. Interactions of ghrelin signaling pathways with the GH neuroendocrine axis: a new and experimentally tested model. J Mol Endocrinol 2009; 43: 105-119.
43. Steyn FJ, Xie TY, Huang L, Ngo ST, Veldhuis JD, Waters MJ, Chen C. Increased adiposity and insulin correlates with the progressive suppression of pulsatile GH secretion during weight gain. J Endocrinol 2013; 218: 233-244.
44. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402: 656-660.
45. Yokote R, Sato M, Matsubara S, Ohye H, Niimi M, Murao K, Takahara J. Molecular cloning and gene expression of growth hormone-releasing peptide receptor in rat tissues. Peptides 1998; 19: 15-20.
46. 125I-labeled ghrelin to membranes from human hypothalamus and pituitary gland. J Endocrinol Invest 2001; 24: RC7-RC9.
47. Guan XM, Yu H, Palyha OC, McKee KK, Feighner SD, Sirinathsinghji DJ, Smith RG, Van der Ploeg LH, Howard AD. Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Brain Res Mol Brain Res 1997; 48: 23-29.
48. Gnanapavan S, Kola B, Bustin SA, Morris DG, McGee P, Fairclough P, Bhattacharya S, Carpenter R, Grossman AB, Korbonits M. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 2002; 87: 2988.
49. Mori K, Kim J, Sasaki K. Electrophysiological effect of ghrelin and somatostatin on rat hypothalamic arcuate neurons in vitro. Peptides 2010; 31: 1139-1145.
50. Willesen MG, Kristensen P, Romer J. Co-localization of growth hormone secretagogue receptor and NPY mRNA in the arcuate nucleus of the rat. Neuroendocrinology 1999; 70: 306-316.
51. Tannenbaum GS, Lapointe M, Beaudet A, Howard AD. Expression of growth hormone secretagogue-receptors by growth hormone-releasing hormone neurons in the mediobasal hypothalamus. Endocrinology 1998; 139: 4420-4423.
52. Wren AM, Small CJ, Fribbens CV, Neary NM, Ward HL, Seal LJ, Ghatei MA, Bloom SR. The hypothalamic mechanisms of the hypophysiotropic action of ghrelin. Neuroendocrinology 2002; 76: 316-324.
53. Tannenbaum GS, Epelbaum J, Bowers CY. Interrelationship between the novel peptide ghrelin and somatostatin/growth hormone-releasing hormone in regulation of pulsatile growth hormone secretion. Endocrinology 2003; 144: 967-974.
54. Osterstock G, Escobar P, Mitutsova V, Gouty-Colomer LA, Fontanaud P, Molino F, Fehrentz JA, Carmignac D, Martinez J, Guerineau NC, Robinson I, Mollard P, Mery PF. Ghrelin stimulation of growth hormone-releasing hormone neurons is direct in the arcuate nucleus. PLoS ONE 2010; 5: e9159.
55. Tolle V, Zizzari P, Tomasetto C, Rio MC, Epelbaum J, Bluet-Pajot MT. In vivo and in vitro effects of ghrelin/motilin-related peptide on growth hormone secretion in the rat. Neuroendocrinology 2001; 73: 54-61.
56. Polkowska J, Wankowska M, Romanowicz K, Gajewska A, Misztal T, Wojcik-Gladysz A. The effect of intracerebroventricular infusions of ghrelin and/or short fasting on the gene expression and immunoreactivity of somatostatin in the hypothalamic neurons and on pituitary growth hormone in prepubertal female lambs. Morphological arguments.Brain Res 2011; 1414: 41-49.
57. Al-Massadi O, Trujillo ML, Senaris R, Pardo M, Castelao C, Casanueva FF, Seoane LM. The vagus nerve as a regulator of growth hormone secretion. Regul Pept 2011; 166: 3-8.
58. Hassouna R, Zizzari P, Tomasetto C, Veldhuis JD, Fiquet O, Labarthe A, Cognet J, Steyn F, Chen C, Epelbaum J, Tolle V. An early reduction in GH peak amplitude in preproghrelin-deficient male mice has a minor impact on linear growth. Endocrinology 2014; 155: 3561-3571.
59. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S. A role for ghrelin in the central regulation of feeding. Nature 2001; 409: 194-198.
60. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature 2000; 407: 908-913.
61. Cornford AS, Barkan AL, Horowitz JF. Rapid suppression of growth hormone concentration by overeating: potential mediation by hyperinsulinemia. J Clin Endocrinol Metab 2011; 96: 824-830.
62. Cornford AS, Barkan AL, Hinko A, Horowitz JF. Suppression in growth hormone during overeating ameliorates the increase in insulin resistance and cardiovascular disease risk. Am J Physiol Endocrinol Metab 2012; 303: E1264-E1272.
63. Goldstein JL, Zhao TJ, Li RL, Sherbet DP, Liang G, Brown MS. Surviving starvation: essential role of the ghrelin-growth hormone axis. Cold Spring Harb Symp Quant Biol 2011; 76: 121-127.
64. Gahete MD, Cordoba-Chacon J, Luque RM, Kineman RD. The rise in growth hormone during starvation does not serve to maintain glucose levels or lean mass but is required for appropriate adipose tissue response in female mice. Endocrinology 2013; 154: 263-269.
65. Huda MS, Dovey TM, Wong SP, English PJ, Halford JC, McCulloch P, Cleator J, Martin B, Cashen J, Hayden K, Ghatei MA, Bloom SR, Wilding JP, Pinkney JH. Ghrelin does not orchestrate the metabolic changes seen in fasting but has significant effects on lipid mobilisation and substrate utilisation. Eur J Endocrinol 2011; 165: 45-55.
66. Yi CX, Heppner KM, Kirchner H, Tong J, Bielohuby M, Gaylinn BD, Muller TD, Bartley E, Davis HW, Zhao Y, Joseph A, Kruthaupt T, Ottaway N, Kabra D, Habegger KM, Benoit SC, Bidlingmaier M, Thorner MO, Perez-Tilve D, Tschop MH, Pfluger PT. The GOAT-ghrelin system is not essential for hypoglycemia prevention during prolonged calorie restriction. PLoS ONE 2012; 7: e32100.
67. Zhao TJ, Liang G, Li RL, Xie X, Sleeman MW, Murphy AJ, Valenzuela DM, Yancopoulos GD, Goldstein JL, Brown MS. Ghrelin O-acyltransferase (GOAT) is essential for growth hormone-mediated survival of calorie-restricted mice. Proc Natl Acad Sci USA 2010; 107: 7467-7472.
68. McFarlane MR, Brown MS, Goldstein JL, Zhao TJ. Induced ablation of ghrelin cells in adult mice does not decrease food intake, body weight, or response to high-fat diet. Cell Metab 2014; 20: 54-60.
69. Stanley S, Domingos AI, Kelly L, Garfield A, Damanpour S, Heisler L, Friedman J. Profiling of glucose-sensing neurons reveals that GHRH neurons are activated by hypoglycemia. Cell Metab 2013; 18: 596-607.
70. Chang GQ, Karatayev O, Davydova Z, Wortley K, Leibowitz SF. Glucose injection reduces neuropeptide Y and agouti-related protein expression in the arcuate nucleus: a possible physiological role in eating behavior. Brain Res Mol Brain Res 2005; 135: 69-80.
71. Fioramonti X, Contie S, Song Z, Routh VH, Lorsignol A, Penicaud L. Characterization of glucosensing neuron subpopulations in the arcuate nucleus: integration in neuropeptide Y and pro-opio melanocortin networks? Diabetes 2007; 56: 1219-1227.
72. McDonald JK, Koenig JI, Gibbs DM, Collins P, Noe BD. High concentrations of neuropeptide Y in pituitary portal blood of rats. Neuroendocrinology 1987; 46: 538-541.
73. Hill JW, Urban JH, Xu M, Levine JE. Estrogen Induces Neuropeptide Y (NPY) Y1 receptor gene expression and responsiveness to NPY in gonadotrope-enriched pituitary cell cultures. Endocrinology 2004; 145: 2283-2290.
74. Adams EF, Venetikou MS, Woods CA, Lacoumenta S, Burrin JM. Neuropeptide Y directly inhibits growth hormone secretion by human pituitary somatotropic tumours. Acta Endocrinol 1987; 115: 149-154.
75. Clarke I, Jessop D, Millar R, Morris M, Bloom S, Lightman S, Coen CW, Lew R, Smith I. Many peptides that are present in the external zone of the median eminence are not secreted into the hypophysial portal blood of sheep. Neuroendocrinology 1993; 57: 765-775.
76. Ogasawara H, Aso H, Nagai Y, Matsumoto K, Okamura H, Tanaka S, Watanabe K, Ohwada S, Yamaguchi T. Presence of neuropeptide Y in somatotrophs of cattle. Domest Anim Endocrinol 2008; 35: 274-280.
77. Grouzmann E, Deruaz JP, Gomez F, Waeber G. Immunolocalization of neuropeptide Y in human pituitary tumours. Regul Pept 1998; 75-76: 89-92.
78. Watanobe H, Tamura T. Stimulatory and inhibitory effects of neuropeptide Y on growth hormone secretion in acromegaly in vivo. Neuropeptides 1997; 31: 29-34.
79. Schaeffer M, Langlet F, Lafont C, Molino F, Hodson DJ, Roux T, Lamarque L, Verdie P, Bourrier E, Dehouck B, Baneres JL, Martinez J, Mery PF, Marie J, Trinquet E, Fehrentz JA, Prevot V, Mollard P. Rapid sensing of circulating ghrelin by hypothalamic appetite-modifying neurons. Proc Natl Acad Sci USA 2013; 110: 1512-1517.
80. Le Tissier PR, Hodson DJ, Lafont C, Fontanaud P, Schaeffer M, Mollard P. Anterior pituitary cell networks. Front Neuroendocrinol 2012; 33: 252-266.
81. Hodson DJ, Romano N, Schaeffer M, Fontanaud P, Lafont C, Fiordelisio T, Mollard P. Coordination of calcium signals by pituitary endocrine cells in situ. Cell Calcium 2012; 51: 222-230.
82. Perez-Castro C, Renner U, Haedo MR, Stalla GK, Arzt E. Cellular and molecular specificity of pituitary gland physiology. Physiol Rev 2012; 92: 1-38.
83. Yin W, Gore AC. The hypothalamic median eminence and its role in reproductive aging. Ann NY Acad Sci 2010; 1204: 113-122.
84. Rodriguez EM, Blazquez JL, Pastor FE, Pelaez B, Pena P, Peruzzo B, Amat P. Hypothalamic tanycytes: a key component of brain-endocrine interaction. Int Rev Cytol 2005; 247: 89-164.
85. Schaeffer M, Hodson DJ, Lafont C, Mollard P. Endocrine cells and blood vessels work in tandem to generate hormone pulses. J Mol Endocrinol 2011; 47: R59-R66.
86. Hodson DJ, Mollard P. Navigating pituitary structure and function - defining a roadmap for hormone secretion. J Neuroendocrinol 2013; 25: 674-675.
87. Hodson DJ, Molino F, Fontanaud P, Bonnefont X, Mollard P. Investigating and modelling pituitary endocrine network function. J Neuroendocrinol 2010; 22: 1217-1225.
88. Johnson AK, Gross PM. Sensory circumventricular organs and brain homeostatic pathways. FASEB J 1993; 7: 678-686.
89. Prevot V, Langlet F, Dehouck B. Flipping the tanycyte switch: how circulating signals gain direct access to the metabolic brain. Aging 2013; 5: 332-334.
90. Balland E, Dam J, Langlet F, Caron E, Steculorum S, Messina A, Rasika S, Falluel-Morel A, Anouar Y, Dehouck B, Trinquet E, Jockers R, Bouret SG, Prevot V. Hypothalamic tanycytes are an ERK-gated conduit for leptin into the brain. Cell Metab 2014; 19: 293-301.
91. Collden G, Balland E, Parkash J, Caron E, Langlet F, Prevot V, Bouret SG. Neonatal overnutrition causes early alterations in the central response to peripheral ghrelin. Mol Metab 2015; 4: 15-24.
92. Langlet F, Levin BE, Luquet S, Mazzone M, Messina A, Dunn-Meynell AA, Balland E, Lacombe A, Mazur D, Carmeliet P, Bouret SG, Prevot V, Dehouck B. Tanycytic VEGF-A boosts blood-hypothalamus barrier plasticity and access of metabolic signals to the arcuate nucleus in response to fasting. Cell Metab 2013; 17: 607-617.
93. Osterstock G, El Yandouzi T, Romano N, Carmignac D, Langlet F, Coutry N, Guillou A, Schaeffer M, Chauvet N, Vanacker C, Galibert E, Dehouck B, Robinson IC, Prevot V, Mollard P, Plesnila N, Mery PF. Sustained alterations of hypothalamic tanycytes during posttraumatic hypopituitarism in male mice. Endocrinology 2014; 155: 1887-1898.
94. Diaz-Flores L, Gutierrez R, Madrid JF, Varela H, Valladares F, Acosta E, Martin-Vasallo P, Diaz-Flores L Jr. Pericytes. Morphofunction, interactions and pathology in a quiescent and activated mesenchymal cell niche. Histol Histopathol 2009; 24: 909-969.
95. Winkler EA, Bell RD, Zlokovic BV. Central nervous system pericytes in health and disease. Nat Neurosci 2011; 14: 1398-1405.
96. Lafont C, Desarmenien MG, Cassou M, Molino F, Lecoq J, Hodson D, Lacampagne A, Mennessier G, El Yandouzi T, Carmignac D, Fontanaud P, Christian H, Coutry N, Fernandez-Fuente M, Charpak S, Le Tissier P, Robinson IC, Mollard P. Cellular in vivo imaging reveals coordinated regulation of pituitary microcirculation and GH cell network function. Proc Natl Acad Sci USA 2010; 107: 4465-4470.
97. Japon MA, Rubinstein M, Low MJ. In situ hybridization analysis of anterior pituitary hormone gene expression during fetal mouse development. J Histochem Cytochem 1994; 42: 1117-1125.
98. Bonnefont X, Lacampagne A, Sanchez-Hormigo A, Fino E, Creff A, Mathieu MN, Smallwood S, Carmignac D, Fontanaud P, Travo P, Alonso G, Courtois-Coutry N, Pincus SM, Robinson IC, Mollard P. Revealing the large-scale network organization of growth hormone-secreting cells. Proc Natl Acad Sci USA 2005; 102: 16880-16885.
99. Tan HY, Huang L, Simmons D, Veldhuis JD, Steyn FJ, Chen C. Hypothalamic distribution of somatostatin mRNA expressing neurones relative to pubertal and adult changes in pulsatile growth hormone secretion in mice. J Neuroendocrinol 2013; 25: 910-919.
100. Sanchez-Cardenas C, Fontanaud P, He Z, Lafont C, Meunier AC, Schaeffer M, Carmignac D, Molino F, Coutry N, Bonnefont X, Gouty-Colomer LA, Gavois E, Hodson DJ, Le Tissier P, Robinson IC, Mollard P. Pituitary growth hormone network responses are sexually dimorphic and regulated by gonadal steroids in adulthood. Proc Natl Acad Sci USA 2010; 107: 21878-21883.
101. Le Tissier PR, Carmignac DF, Lilley S, Sesay AK, Phelps CJ, Houston P, Mathers K, Magoulas C, Ogden D, Robinson IC. Hypothalamic growth hormone-releasing hormone (GHRH) deficiency: targeted ablation of GHRH neurons in mice using a viral ion channel transgene. Mol Endocrinol 2005; 19: 1251-1262.
102. In't Veld PA, Pipeleers DG, Gepts W. Glucose alters configuration of gap junctions between pancreatic islet cells. Am J Physiol 1986; 251: C191-C196.
103. Kreier F, Swaab DF. History of neuroendocrinology 'the spring of primitive existence'. Handb Clin Neurol 2010; 95: 335-360.